News
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
Explore more
2d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
2d
Cryptopolitan on MSNMeta shareholders test boundaries as they drag Zuckerberg and top board members to courtMeta’s executives will meet in a Delaware court starting Wednesday over a lawsuit filed by three minority shareholders who ...
The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...
Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results